Epidemiology and screening of colon cancer;Épidémiologie et recommandations pour le dépistage du cancer colorectal

Revue du Praticien

Volumn 60, Issue 8, 2010, Pages 1062-1067

  Lepage, Côme ^b   Hamza, Samia ^b   Faivre, Jean ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL PROTOCOL; CLINICAL TRIAL; COLITIS; COLON ADENOMA; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; EUROPEAN UNION; FRANCE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HIGH RISK PATIENT; HUMAN; OCCULT BLOOD TEST; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PROCTOCOLECTOMY; PROCTOCOLITIS; REVIEW; RISK FACTOR; ARTICLE; COLON TUMOR; GENETIC PREDISPOSITION; OCCULT BLOOD; RISK ASSESSMENT;

COLONIC NEOPLASMS; COLONOSCOPY; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OCCULT BLOOD; RISK ASSESSMENT;

EID: 78149265286     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Belot A, Grosclaude P, Bossard N, et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Santé Publique 2008;56:159-75.
2. Colonna M, Danzon A, Delafosse P, et al. Cancer prevalence in France: times trends, situation in 2002 and extrapolation to 2012. Eur J Cancer 2008;4:115-22.
3. Devesa S, Blot W, Stone B, Miller B, Tarone R, Fraumeni J. Recent cancer trends in the United States. J Natl Cancer Inst 1995;87.1775-82.
4. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, Vol. IX. Lyon: Scientific Publications, IARC; 2007.
5. Chauvenet M, Lepage C, Jooste V, Cottet V, Faivre J, Bouvier AM. Prevalence of patients with colorectal cancer requiring follow-up or active treatment. Eur J Cancer 2009;4.1460-5.
6. Cress RD, Morris C, Ellison GL, Goodman MT. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001. Cancer 2006;107:S1142-52.
7. Lepage C, Remontet L, Launoy G, et al. French network of cancer registries (FRANCIM). Trends in incidence of digestive cancers in France. Eur J Cancer Prev 2008;17:13-7.
8. Bouvier AM, Remontet L, Hedelin G, et al. Conditional relative survival of cancer patients and conditional probability of death: a French national database analysis. Cancer 2009;115:4616-24.
9. Rebischung C, Laurent-Pulg P, Gerard JP, Thomas G, Hamelin R. Analyse des altérations génétiques du cancer du rectum: différences par rapport au cancer du côlon. Gastroenterol Clin Biol 1998;22:679-87.
10. Baglietto L, Jenkins MA, Severi G, et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 2006;59:114-24.
11. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006;42:216-27.
12. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001;96:2992-3003.
13. St John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-90.
14. Fuchs C, Giovannucci E, Colditz G, Hunter D, Speizer F, Willett W. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-94.
15. Cottet V, Pariente A, Nalet B, et al. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology 2007;13:1086-92.
16. Chow JS, Chen CC, Ahsan H, Neugut AI. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int J Epidemiol 1996;25:722-8.
17. Winawer S, Faivre J, Selby J, et al. Workgroup II: the screening process. UICC international workshop on facilitating screening for colorectal cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol 2005;16:31-3.
18. Atkin W, Morson B, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-62.
19. Neugut AI, Jacobson JS, Rella VA. Prevalence and incidence of colorectal adenomas and cancer in asymptomatic persons. Gastrointest Endosc Clin N Am 1997;7:387-99.
20. Cottet V, Jooste V, Bouvier AM, Michlels C, Faivre J, Bonithon-Kopp C. Time trends in first-diagnosis rates of colorectal adenomas - a 24-year population-based study. Aliment Pharmacol Ther 2008;27:950-9.
21. Bouvier AM, Latournerie M, Jooste V, Lepage C, Cottet V, Faivre J. The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up. Eur J Cancer 2008;44:522-7.
22. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004;126:1634-48.
23. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
24. Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005;100:2724-9.
25. Percesepe A, Borghi F, Menigatti M, et al. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol 2001;19:3944-50.
26. Ponz de Leon M, Benatti P, Borghi F, et al. Aetiology of colorectal cancer and relevance of monogenic inheritance. Gut 2004;53:115-22.
27. Vasen H, Wijnen J, Menko F, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-27.
28. www.snfge.asso.fr/01-Bibliotheque/OG-Thesaurus-cancerologie/. Thésaurus de cancérologie digestive. SNFGE, 2007.
29. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003;21:1174-9.
30. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-34.
31. Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C - >T:A mutations in colorectal tumors. Nat Genet 2002;30:227-32.
32. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003,348:791-9.
33. Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003;362:39-41.
34. Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004;126:1674-80.
35. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
36. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
37. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
38. Tazi MA, Faivre J, Dassonville F, Lamour J, Milan C, Durand G. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen 1997;4:147-51.
39. Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 2008;44:2254-8.
40. Guittet L, Bouvier V, Mariotte N, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007;56:210.
41. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer randomised trial comparing gaïac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62-8.